A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer
Improved therapeutics are needed for treating breast cancer. Here they show the druggability of myoferlin with a small molecule inhibitor in breast cancer and demonstrate its anti-breast cancer effects in vitro and in vivo.
Guardado en:
Autores principales: | Tao Zhang, Jingjie Li, Yuan He, Feifei Yang, Yun Hao, Wangrui Jin, Jing Wu, Zhenliang Sun, Yunqi Li, Yihua Chen, Zhengfang Yi, Mingyao Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a73b563276a4425294fa01eeae77ed30 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Loss of dysferlin or myoferlin results in differential defects in excitation–contraction coupling in mouse skeletal muscle
por: David Y. Barefield, et al.
Publicado: (2021) -
A novel hydrazide compound exerts anti-metastatic effect against breast cancer
por: Dehghani,Soudeh, et al.
Publicado: (2019) -
Small Molecules, Big Promises: Improvement of Psoriasis Severity and Glucidic Markers with Apremilast: A Case Report
por: Lanna C, et al.
Publicado: (2019) -
Exploration of promising optical and electronic properties of (non-polymer) small donor molecules for organic solar cells
por: Muhammad Khalid, et al.
Publicado: (2021) -
An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies
por: Alison Findlay, et al.
Publicado: (2021)